A new partnership to improve TB treatments around the world

New TB drugs are safe, effective alternatives

Patient holding his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which he is taking for the first time today.


13 July 2018

New interim findings from endTB indicate bedaquiline and delamanid could benefit many more patients.


Q&A: endTB clinical trial, one year on

Bedaquiline. (Daro Sulakauri / MSF)


24 March 2018

On World TB Day Dr. Lorenzo Guglielmetti, endTB trial co-principal investigator, takes stock of progress in the trial's first year.


PIH MSF (541) 893-0813 UNITAID